Stay updated with breaking news from Daniel Bradbury. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]
The site of a former pub in Slough which was demolished seven years ago and has been dormant ever since is finally set for development.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.45, for a total value of $196,310.40. Following the completion of the sale, the director now directly owns 22,782 shares of […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of Castle Biosciences stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.45, for a total value of $196,310.40. Following the transaction, the director now owns 22,782 shares in the company, […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,420,000 shares, an increase of 17.4% from the February 29th total of 1,210,000 shares. Based on an average daily trading volume, of 252,100 shares, the short-interest […]